| 0 (0%) | 11-11 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 41.75  |
1-year : | 48.77 |
| Resists | First : | 35.75 |
Second : | 41.75 |
| Pivot price | 34.18 |
|||
| Supports | First : | 33.68 |
Second : | 32.4 |
| MAs | MA(5) : | 34.71 |
MA(20) : | 33.98 |
| MA(100) : | 34.68 |
MA(250) : | 33.7 |
|
| MACD | MACD : | 0 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 92.7 |
D(3) : | 83 |
| RSI | RSI(14): 61.7 |
|||
| 52-week | High : | 38.84 | Low : | 29.31 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ RDN ] has closed Bollinger Bands are 10.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 35.62 - 35.76 | 35.76 - 35.91 |
| Low: | 34.22 - 34.37 | 34.37 - 34.54 |
| Close: | 35.05 - 35.29 | 35.29 - 35.57 |
Sat, 08 Nov 2025
Decoding Radian Group Inc (RDN): A Strategic SWOT Insight - GuruFocus
Fri, 07 Nov 2025
Radian Group (RDN): Evaluating Share Valuation After Mixed Q3 Results Reveal Revenue Decline, EPS Growth - simplywall.st
Thu, 06 Nov 2025
Ray Cohen sizes up the renal denervation market after $600M SoniVie sale - Medical Design & Outsourcing
Thu, 06 Nov 2025
Medtronic names its next-gen renal denervation catheter as it builds the RDN market - Medical Design & Outsourcing
Thu, 06 Nov 2025
Radian Group (RDN): Margin Pressure Challenges Bullish Value Narrative Despite Strong Relative Valuation - Yahoo Finance
Wed, 05 Nov 2025
Radian Group Inc (RDN) Q3 2025 Earnings Call Highlights: Record Mortgage Insurance Portfolio ... - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 135 (M) |
| Shares Float | 134 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 96.2 (%) |
| Shares Short | 5,820 (K) |
| Shares Short P.Month | 6,590 (K) |
| EPS | 3.96 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 33.18 |
| Profit Margin | 45.6 % |
| Operating Margin | 63.1 % |
| Return on Assets (ttm) | 6.1 % |
| Return on Equity (ttm) | 13 % |
| Qtrly Rev. Growth | -1 % |
| Gross Profit (p.s.) | 8.78 |
| Sales Per Share | 9.52 |
| EBITDA (p.s.) | 6.89 |
| Qtrly Earnings Growth | 4 % |
| Operating Cash Flow | -1,150 (M) |
| Levered Free Cash Flow | 637 (M) |
| PE Ratio | 8.95 |
| PEG Ratio | 0 |
| Price to Book value | 1.06 |
| Price to Sales | 3.72 |
| Price to Cash Flow | -4.18 |
| Dividend | 0.25 |
| Forward Dividend | 0 |
| Dividend Yield | 0.7% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|